Medical Devices
Medical Device Coordination Group Document MDCG 2024-10
1
MDCG 2024-10
Clinical evaluation of orphan
medical devices
June 202
30.03.2026
Datei
PD
Medical Device
Medical Device Coordination Group Document MDCG 2024-3
1
MDCG 2024-3
Guidance on content of the Clinical
Inve
30.03.2026
Datei
PD
Medical Devices
Medical Device Coordination Group Document MDCG 2024-4
Page 1 of 23
MDCG 2024-4
Safety reporting in performance studies of in vitro
diagnostic medical de
30.03.2026
Datei
PD
Medical Device
Medical Device Coordination Group Document MDCG 2024-5
MDCG 2024-5
guidance on content of the Investigator’s Brochure for
clinical in
30.03.2026
Datei
PD
Medical Device Coordination Group Document MDCG 2024-12
applicable for M
30.03.2026
Datei
PD
Medical Device
Medical Device Coordination Group Document MDCG 2023-7
1(12)
MDCG 2023-7
Guidance on exemptions from the requirement to
perfor
30.03.2026
Datei
PD
Medical Devices
Medical Device Coordination Group Document MDCG 2024-1-5
MDCG 2024-1-5
Guidance on the vigilance system
for CE-marked devices
DSVG
30.03.2026
Datei
PD
Medical Devices
Medical Device Coordination Group Document MDCG 2023-6
Page 1 of 4
MDCG 2023-6
Guidance on demonstration of
equivalence for Annex XVI products
A guide
30.03.2026
Datei
PD
1
Ongoing guidance development and deliverables of MDCG Subgroups – March 2023*
*This is not an exhaustive list of ongoing work performed by MDCG Subgroups
Scope Group Deliverables
Consult
30.03.2026
Datei
PD
EU reference dates list
The convention used to present the active substances and combinations of active substances has changed. From the 29th October 2015 the following principles apply:
- A sla
30.03.2026
Datei
PD
